Clinical trial
Drug Utilization Study for Olodaterol
NCT03030638 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Drug Utilization Study for Olodaterol
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 8, 2017
- Completion date
- March 31, 2018
- Enrollment
- 27,606 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.